The DOI matches its Crossref record.
Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine
Abstract
OBJECTIVE: Invasive pneumococcal disease rates have declined since immunization with 7-valent pneumococcal conjugate vaccine (PCV7) (Prevenar/Prevnar [Wyeth Pharmaceuticals, Philadelphia, PA]) became routine. Certain nonvaccine Streptococcus pneumoniae serotypes (1, 3, 5, 6A, 7F, and 19A) still cause significant morbidity and mortality. The safety and immunogenicity of PCV7 were compared with those of 13-valent PCV (PCV13), which contains saccharides from serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F conjugated to CRM197. PATIENTS AND METHODS: Infants were randomly assigned to receive PCV13 or PCV7 at ages 2, 4, and 6 months with other vaccines. Post–third-dose antibodies to each pneumococcal polysaccharide were measured by immunoglobulin G enzyme-linked immunosorbent assay. Antibacterial functional antibodies were measured by opsonophagocytic assay (OPA). RESULTS: Subjects received PCV13 (n = 122) or PCV7 (n = 127). All PCV13 serotypes were immunogenic, with 88% to 98% of infants achieving antibody concentrations of ≥0.35 μg/mL to shared PCV7 serotypes. For the 6 additional serotypes, 97% to 100% of PCV13-vaccinated infants achieved antibody concentrations of ≥0.35 μg/mL. Geometric mean antibody concentration for PCV13 recipients ranged from 1.32 μg/mL (serotype 23F) to 4.26 μg/mL (serotype 14). The ratio of OPA geometric mean titers for the 7 shared serotypes (PCV13:PCV7) ranged from 0.6 to 1.4, suggesting no clinically meaningful differences. For PCV13-only serotypes, OPA geometric mean titers were significantly higher in the PCV13 group than in the PCV7 group. Local reactions and systemic events were similar between groups. CONCLUSIONS: PCV13 was well tolerated and immunogenic, with most infants developing antipolysaccharide antibody concentrations of ≥0.35 μg/mL, as well as OPA responses, to each of the 13 serotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Isaacman, D. J., McIntosh, E. D., & Reinert, R. R. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.05.010 · Cited by 321
Daniels, C. C., Rogers, P. D., & Shelton, C. M. (2016) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-21.1.27 · Cited by 273
Vaccines, adjuvants and autoimmunity
Guimarães, L. E., Baker, B., Perricone, C., & Shoenfeld, Y. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.08.003 · Cited by 262
Protein carriers of conjugate vaccines: Characteristics, development and clinical trials
Pichichero, M. E. (2013) · Human vaccines & immunotherapeutics · doi:10.4161/hv.26109 · Cited by 261
Tashani, M., Heron, L., Wong, M., Rashid, H., & Booy, R. (2017) · Journal of Travel Medicine · doi:10.1093/jtm/tax006 · Cited by 19
Metadata
- Authors
- Bryant, K. A., Block, S. L., Baker, S. A., Gruber, W. C., Scott, D. A., & for the PCV13 Infant Study Group
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2010-05-01
- Volume
- 125
- Issue
- 5
- Pages
- 866-875
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2094689350
- Cited by
- 186
- References
- 0
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine. https://app.cochat.ai/papers/10.1542/peds.2009-1405
- The paper
- Bryant, K. A., Block, S. L., Baker, S. A., Gruber, W. C., Scott, D. A., & for the PCV13 Infant Study Group. (2010). Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine. Pediatrics. https://doi.org/10.1542/peds.2009-1405
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.